Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 40886 record(s)

Req # A-2016-000148

The records generated within Health Canada regarding the Attawapiskat crisis in HC from April 1, 2016 to April 26, 2016.

Organization: Health Canada

390 page(s)
December 2020

Req # A-2017-000314

The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for EPREX (Epoetin) by Janssen Inc.

Organization: Health Canada

58 page(s)
December 2020

Req # A-2017-001357

All correspondence at an Assistant Deputy Minister (ADM) level or above regarding medical cannabis re: smoke, topicals and edibles from April - June 2017.

Organization: Health Canada

4 page(s)
December 2020

Req # A-2020-000707

Adverse Reaction Reports (AERs). Report numbers: E2B_02748964, E2B_02978453, 000730851, E2B_02799042, E2B_02682822.

Organization: Health Canada

74 page(s)
December 2020

Req # A-2019-001583

All records detailing what was discussed at each meeting of the Deputy Ministers’ Breakfast (DMB) committee over the past six months.

Organization: Health Canada

31 page(s)
December 2020

Req # A-2020-001024

Heath Canada’s documents that discussed the 2015 scheduling initiative pertaining to 2C-phenthylamines--especially the intended scope of substituted phenethylamines, and nomenclature for the intended substituted phenethylamines.

Organization: Health Canada

46 page(s)
December 2020

Req # A-2020-000657

All records regarding this article in The Logic: "Canadian tech companies that pivoted to making ventilators drawing global interest".

Organization: Health Canada

6 page(s)
December 2020

Req # A-2019-000092

Adverse Reaction Reports (AERs) for VEDOLIZUMAB. Report numbers: 717972, 720568, E2B_02098024, E2B_02110651, E2B_02135149, E2B_02136657, E2B_02159265, E2B_02165562, E2B_02168390, E2B_02171111, E2B_02187319, E2B_02188869, E2B_02201833, E2B_02210945,…

Organization: Health Canada

264 page(s)
December 2020

Req # A-2019-001066

Adverse Reaction Reports (AERs). Report numbers: 000643741, E2B_01509440, E2B_01969476, E2B_02062978, E2B_01466237, E2B_02107619, 00071681, 000718241, E2B_01651619, E2B_00583874, E2B_02103075.

Organization: Health Canada

213 page(s)
December 2020

Req # A-2019-001267

Adverse Reaction Reports (AERs). Report numbers: 000725284, 000725318, 000725522, 000726063, 000726157.

Organization: Health Canada

30 page(s)
December 2020
Date modified: